Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 176

Similar articles for PubMed (Select 23954771)

1.

Alpha-fetoprotein-L3 in hepatocellular carcinoma: a meta-analysis.

Yi X, Yu S, Bao Y.

Clin Chim Acta. 2013 Oct 21;425:212-20. doi: 10.1016/j.cca.2013.08.005. Epub 2013 Aug 13. Review.

PMID:
23954771
2.

Sublingual vein parameters, AFP, AFP-L3, and GP73 in patients with hepatocellular carcinoma.

Zhao J, Guo LY, Yang JM, Jia JW.

Genet Mol Res. 2015 Jun 26;14(2):7062-7. doi: 10.4238/2015.June.26.16.

PMID:
26125916
3.

Development and Internal Validation of a Model for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis.

Patel J, Yopp A, Waljee A, Singal AG.

J Clin Gastroenterol. 2015 Jun 25. [Epub ahead of print]

PMID:
26125462
4.

Potential Role of Circulating microRNA-21 for Hepatocellular Carcinoma Diagnosis: A Meta-Analysis.

Liao Q, Han P, Huang Y, Wu Z, Chen Q, Li S, Ye J, Wu X.

PLoS One. 2015 Jun 26;10(6):e0130677. doi: 10.1371/journal.pone.0130677. eCollection 2015.

5.

Highly sensitive alpha-fetoprotein, Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin for hepatocellular carcinoma detection.

Caviglia GP, Abate ML, Petrini E, Gaia S, Rizzetto M, Smedile A.

Hepatol Res. 2015 Jun 17. doi: 10.1111/hepr.12544. [Epub ahead of print]

PMID:
26082262
6.

Serum Alpha-Fetoprotein Has High Specificity for the Early Detection of Hepatocellular Carcinoma After Hepatitis C Virus Eradication in Patients.

Minami T, Tateishi R, Kondo M, Nakagomi R, Fujiwara N, Sato M, Uchino K, Enooku K, Nakagawa H, Asaoka Y, Kondo Y, Moriya K, Shiina S, Koike K.

Medicine (Baltimore). 2015 Jun;94(23):e901. doi: 10.1097/MD.0000000000000901.

PMID:
26061310
7.

[Diagnostic value of serum Golgi protein-73 (GP73) combined with AFP-L3% in hepatocellular carcinoma: a meta-analysis].

Shi M, Huang Z, Yang Y, Zhao B.

Zhonghua Gan Zang Bing Za Zhi. 2015 Mar;23(3):189-93. doi: 10.3760/cma.j.issn.1007-3418.2015.03.007. Chinese.

PMID:
25938831
8.

Skeletal muscle depletion predicts the prognosis of patients with hepatocellular carcinoma treated with sorafenib.

Imai K, Takai K, Hanai T, Ideta T, Miyazaki T, Kochi T, Suetsugu A, Shiraki M, Shimizu M.

Int J Mol Sci. 2015 Apr 28;16(5):9612-24. doi: 10.3390/ijms16059612.

9.

Prediction of the severity of acute pancreatitis on admission by carboxypeptidase-B activation peptide: A systematic review and meta-analysis.

Deng L, Wang L, Yong F, Xiong J, Jin T, De La Iglesia-Garcia D, Bharucha S, Altaf K, Huang W, Xia Q.

Clin Biochem. 2015 Jul;48(10-11):740-6. doi: 10.1016/j.clinbiochem.2015.04.018. Epub 2015 Apr 25. Review.

PMID:
25920892
10.

Serum thioredoxin is a diagnostic marker for hepatocellular carcinoma.

Li J, Cheng ZJ, Liu Y, Yan ZL, Wang K, Wu D, Wan XY, Xia Y, Lau WY, Wu MC, Shen F.

Oncotarget. 2015 Apr 20;6(11):9551-63.

11.
12.

Value of quantitative and qualitative analyses of circulating cell-free DNA as diagnostic tools for hepatocellular carcinoma: a meta-analysis.

Liao W, Mao Y, Ge P, Yang H, Xu H, Lu X, Sang X, Zhong S.

Medicine (Baltimore). 2015 Apr;94(14):e722. doi: 10.1097/MD.0000000000000722.

PMID:
25860220
13.

Significant biomarkers for the management of hepatocellular carcinoma.

Kondo Y, Kimura O, Shimosegawa T.

Clin J Gastroenterol. 2015 Jun;8(3):109-15. doi: 10.1007/s12328-015-0568-9. Epub 2015 Apr 9.

PMID:
25855582
14.

Serum Dickkopf-1 as a biomarker for the diagnosis of hepatocellular carcinoma.

Jeng JE, Chuang LY, Chuang WL, Tsai JF.

Chin Clin Oncol. 2012 Sep;1(1):4. doi: 10.3978/j.issn.2304-3865.2012.08.03.

15.

Golgi protein 73 as a biomarker for hepatocellular carcinoma: A diagnostic meta-analysis.

Yang J, Li J, Dai W, Wang F, Shen M, Chen K, Cheng P, Zhang Y, Wang C, Zhu R, Zhang H, Zheng Y, Wang J, Xia Y, Lu J, Zhou Y, Guo C.

Exp Ther Med. 2015 Apr;9(4):1413-1420. Epub 2015 Jan 29.

16.

Estimation of leucine aminopeptidase and 5-nucleotidase increases alpha-fetoprotein sensitivity in human hepatocellular carcinoma cases.

Abouzied MM, Eltahir HM, Fawzy MA, Abdel-Hamid NM, Gerges AS, El-Ibiari HM, Nazmy MH.

Asian Pac J Cancer Prev. 2015;16(3):959-63.

17.

Combination of exosomes and circulating microRNAs may serve as a promising tumor marker complementary to alpha-fetoprotein for early-stage hepatocellular carcinoma diagnosis in rats.

Liu WH, Ren LN, Wang X, Wang T, Zhang N, Gao Y, Luo H, Navarro-Alvarez N, Tang LJ.

J Cancer Res Clin Oncol. 2015 Feb 28. [Epub ahead of print]

PMID:
25724413
18.

Plasma interleukin 17 in the diagnosis of hepatocellular carcinoma: a retrospective study of 39 cases.

Liu J, Zhou G, Lu W.

J Cancer Res Ther. 2014 Dec;10 Suppl:304-6. doi: 10.4103/0973-1482.151537.

19.

Hepatocellular carcinoma in tyrosinemia type 1 without clear increase of AFP.

van Ginkel WG, Gouw AS, van der Jagt EJ, de Jong KP, Verkade HJ, van Spronsen FJ.

Pediatrics. 2015 Mar;135(3):e749-52. doi: 10.1542/peds.2014-1913. Epub 2015 Feb 9.

PMID:
25667247
20.

Preoperative evaluation of the histological grade of hepatocellular carcinoma with diffusion-weighted imaging: a meta-analysis.

Chen J, Wu M, Liu R, Li S, Gao R, Song B.

PLoS One. 2015 Feb 6;10(2):e0117661. doi: 10.1371/journal.pone.0117661. eCollection 2015.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk